AU2001239313A1 - Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds - Google Patents

Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds

Info

Publication number
AU2001239313A1
AU2001239313A1 AU2001239313A AU3931301A AU2001239313A1 AU 2001239313 A1 AU2001239313 A1 AU 2001239313A1 AU 2001239313 A AU2001239313 A AU 2001239313A AU 3931301 A AU3931301 A AU 3931301A AU 2001239313 A1 AU2001239313 A1 AU 2001239313A1
Authority
AU
Australia
Prior art keywords
delivery
containing compounds
derivatives useful
nucleotide containing
dihydropyridine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001239313A
Other languages
English (en)
Inventor
Brigita Cekavicus
Gunars Duburs
Zanna Hyvonen
Ilpo Jaaskelainen
Aivars Krauze
Natalja Makarova
Aiva Plotniece
Inese Reine
Andulis Shmidlers
Gunars Tirzitis
Marjo-Riitta Toppinen
Mikko Turunen
Arto Urtti
Brigita Vigante
Seppo Yla-Herttuala
Raivis Zhalubovskis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HERTTUALA SEPPO YLA
TOPPINEN MARJO RIITTA
Original Assignee
HERTTUALA SEPPO YLA
TOPPINEN MARJO RIITTA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HERTTUALA SEPPO YLA, TOPPINEN MARJO RIITTA filed Critical HERTTUALA SEPPO YLA
Publication of AU2001239313A1 publication Critical patent/AU2001239313A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001239313A 2000-02-23 2001-02-22 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds Abandoned AU2001239313A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20000421 2000-02-23
FI20000421A FI20000421A0 (fi) 2000-02-23 2000-02-23 Nukleotidejä sisältävien yhdisteiden kuljetukseen käyttökelpoisia 1,4-Dihydropyridiinijohdannaisia
PCT/FI2001/000185 WO2001062946A1 (en) 2000-02-23 2001-02-22 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds

Publications (1)

Publication Number Publication Date
AU2001239313A1 true AU2001239313A1 (en) 2001-09-03

Family

ID=8557695

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001239313A Abandoned AU2001239313A1 (en) 2000-02-23 2001-02-22 Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds

Country Status (6)

Country Link
US (1) US20030064954A1 (fi)
EP (1) EP1261731A1 (fi)
AU (1) AU2001239313A1 (fi)
CA (1) CA2397669A1 (fi)
FI (1) FI20000421A0 (fi)
WO (1) WO2001062946A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106913523B (zh) * 2017-01-19 2019-11-05 北京师范大学 一氧化氮响应的载药囊泡、制备方法及其应用
CN113966323B (zh) * 2019-06-12 2023-11-28 凯托利皮克斯治疗有限责任公司 一种用于生产酮羧酸多元醇基酯的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981501A (en) * 1995-06-07 1999-11-09 Inex Pharmaceuticals Corp. Methods for encapsulating plasmids in lipid bilayers
US6586413B2 (en) * 1999-11-05 2003-07-01 The United States Of America As Represented By The Department Of Health And Human Services Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists

Also Published As

Publication number Publication date
WO2001062946A8 (en) 2002-05-16
US20030064954A1 (en) 2003-04-03
EP1261731A1 (en) 2002-12-04
WO2001062946A1 (en) 2001-08-30
CA2397669A1 (en) 2001-08-30
FI20000421A0 (fi) 2000-02-23

Similar Documents

Publication Publication Date Title
PL350030A1 (en) Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
HUP0303148A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing the compounds and processes for their preparation
HUP0302230A3 (en) Polyarylcarboxamides useful as lipid lowering agents, process for producing them and pharmaceutical compositions containing them
AU2001289751A1 (en) Selective pde 2 inhibitors, used as medicaments for improving cognition
AU2001247951A1 (en) Novel cationic amphiphiles
HUP0102334A3 (en) Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
AU2001271037A1 (en) Pharmaceutical compositions containing dds compounds
AU2001269198A1 (en) Novel 1,3-dihydro-2h-indol-one derivatives, method for preparing same and pharmaceutical compositions containing them
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
AU4304400A (en) Novel pharmaceutical compositions comprising 2-isoxazole-8-aminotetralin derivatives
AU2001292331A1 (en) 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation
IL140074A0 (en) Process for preparing 1,4-dihydropyridine compounds
AU2002339192A1 (en) 1,2,4-triazole derivatives containing a sulphamate group as aromatase inhibitors
AU2002313065A1 (en) Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
HUP0202379A3 (en) New compounds, process for producing them and pharmaceutical compositions containing them
AU2002210632A1 (en) Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
AU2673201A (en) Alpha-arylethylpiperazine derivatives as neurokinin antagonists
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
AU1018801A (en) Use of 3,4-substituted piperidines
AU2001239313A1 (en) Cationic amphiphilic 1,4-dihydropyridine derivatives useful for delivery of nucleotide containing compounds
HUP0402475A3 (en) Process for the preparation of [1,4,5]-oxadiazepine derivatives
AU5525199A (en) N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
AU6870600A (en) Process for the preparation of 2,3-dihydroazepine compounds
AU6870500A (en) Process for the preparation of 2,3-dihydroazepine derivatives
AU2002214975A1 (en) Novel 1,4-diamino-2-alkenyl-benzene derivatives and colorants containing said compounds